with valid act stalled, should the fda regulate laboratory-developed tests?
Published 1 year ago • 313 plays • Length 4:26Download video MP4
Download video MP3
Similar videos
-
3:19
how the valid act, if passed, can harm patient access to life-saving tests
-
3:22
how labs should prepare for new laboratory developed test rules and what comes next
-
48:15
exploring concerns surrounding the valid act
-
1:01:43
what the fda's final rule means for the future of laboratory developed tests
-
1:01:08
unpacking the fda's new proposed rule for laboratory developed tests
-
8:32
ls-20 tutorial - setup and validation
-
1:57
meet the atlantis agents
-
12:03
my job as a lab manager 🥼| working in a lab | a day in the life 👩🏻🔬
-
12:11
covid-19 lab-developed tests: the fda's evolving approach
-
8:42
covid-19 lab developed tests policy reversal: how did we get here?
-
46:52
the impact of the fda's recent shift on covid ldts and beyond
-
19:22
lab-developed tests: shannon bennett
-
4:11
which tests are impacted by new fda oversight rules?
-
4:30
what are ldts and how are they regulated?
-
1:59
fda works to strengthen 'lab-developed tests'
-
0:38
fda looking to strengthen lab developed test standards
-
1:19:55
fda webinar: regulatory oversight of laboratory developed tests ldts
-
2:39
how medical laboratories are evolving as 2024 approaches
-
4:28
justifying the need for fda regulation of ldts
-
55:54
impending actions on laboratory developed tests (ldts) webinar
-
1:19:55
framework for regulatory oversight of laboratory developed tests (ldts)
-
38:58
challenges of establishing laboratory developed tests